about
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis.Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative studyFrontline Dasatinib Treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia.Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.Analogs, formulations and derivatives of imatinib: a patent review.Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study.Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative StudyThe BCL2L11 deletion polymorphism is not associated with imatinib resistance in chronic myeloid leukemia patients: meta-analysis.Time-series analysis in imatinib-resistant chronic myeloid leukemia K562-cells under different drug treatments.Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.Pregnancy: part of life in chronic myelogenous leukemia.CML - we are not there yet.
P2860
Q30241189-F8B66ABF-FAA9-4AB7-8139-0D25D4D36750Q33813279-160A0840-8E49-4466-9995-A5769F423217Q37273788-2743C61B-D7D7-47C3-B5FE-AFB2BDE49A40Q37696776-F7C47E66-5320-4FFB-B507-52EB1652EDC3Q38587332-043FA215-E6B0-4032-8212-C5D82D14C38CQ38880265-93865ABF-FC5D-46C3-91CA-C6C37B7A336BQ38913462-F97B09C3-5990-4485-85E3-D24854EC20B0Q41144255-287E49DE-23D0-4623-A912-FB0C78F63AA7Q42672759-ADDE617D-910C-4127-8A29-DB2618553050Q47162677-34BC466C-A6AF-42D6-A927-19B0ED01D7EAQ47980151-08D7E1EF-1563-4056-A11E-6D854C5DF4B1Q50976585-6D8E498B-A4EC-474D-AD7A-49A7D8A3ED20Q54186045-8160FD08-B13A-41A1-A997-680DDE53CBEAQ55034957-06D7EF03-A816-43DF-93C0-C4528D5A7F91
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Epidemiology of chronic myeloid leukaemia: an update.
@en
type
label
Epidemiology of chronic myeloid leukaemia: an update.
@en
prefLabel
Epidemiology of chronic myeloid leukaemia: an update.
@en
P2860
P1433
P1476
Epidemiology of chronic myeloid leukaemia: an update.
@en
P2093
Bengt Simonsson
Fredrik Sandin
P2860
P304
P356
10.1007/S00277-015-2314-2
P478
94 Suppl 2
P577
2015-03-27T00:00:00Z